ASTELLAS PHARMACEUTICAL PRIVATE LTD

Astellas Pharmaceutical Private Ltd in Pakistan operates primarily as a **trader and distributor** of pharmaceutical products.

Company Introduction: Astellas Pharmaceutical Private Ltd, Pakistan

Astellas Pharmaceutical Private Ltd in Pakistan is the local subsidiary of Astellas Pharma Inc., a Japanese multinational pharmaceutical company. Its primary function within Pakistan is the import, marketing, sales, and distribution of the parent company's innovative pharmaceutical products.

Astellas Pharma Inc. is a global pharmaceutical company committed to improving the health of people around the world by providing innovative and reliable medicines. The company focuses on developing and delivering treatments in various therapeutic areas, including oncology, urology, immunology, nephrology, and neuroscience.

In Pakistan, Astellas Pharmaceutical Private Ltd ensures that these advanced pharmaceutical treatments reach patients and healthcare providers across the country. While Astellas Pharma Inc. has extensive global research, development, and manufacturing capabilities, the Pakistani entity's core role is to manage the market presence, sales, and distribution network for Astellas products within Pakistan. It acts as the local commercial arm, facilitating access to its global portfolio of medicines.

ASTELLAS PHARMACEUTICAL PRIVATE LTD (Pakistan) sells products primarily in the therapeutic areas of Oncology, Urology, Transplant, and Infectious Diseases.

Key products that Astellas Pharma globally markets and may be available or sold by its subsidiary in Pakistan include:

XTANDI (Enzalutamide) for prostate cancer.

PROGRAF (Tacrolimus) for organ transplant rejection.

VESICARE (Solifenacin) for overactive bladder.

MYRBETRIQ / BETMIGA (Mirabegron) for overactive bladder.

XOSPATA (Gilteritinib) for acute myeloid leukemia.

PADCEV (Enfortumab Vedotin) for urothelial cancer.

CRESEMBA (Isavuconazonium Sulfate) for invasive fungal infections.